Leucovorin for language disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Jul 2016: Trial registered, NCT02839915
  2. 13 Aug 2020: Trial started, NCT02839915

The trials

NCT02839915: Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

State
Under way
Phase
Phase 2
People
56 taking part
Started
13 Aug 2020
Primary completion
15 Apr 2024
Arms
Folinic Acid
Results
None posted
  1. 21 Jul 2016: Trial registered
  2. 13 Aug 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Folinoral, Folinic Acid.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.